News

Ball of neuroblastoma cells forming mature nerves after drug treatment (Credit: Kirsty Ferguson/Developmental Cell)

Philpott Lab discovery could lead to 'kinder' treatment for neuroblastoma

20 September 2023

Neuroblastoma is responsible for 15% of cancer deaths in children. Research out today from the Philpott Lab offers hope to these children, who could in future be given treatments with fewer side-effects than those associated with the current chemotherapy. The approach involves the use of a ‘differentiation therapy’, a type...

SKAN Research Trust and Wellcome-MRC Cambridge Stem Cell Institute to collaborate in stem cell research

6 September 2023

Today (6 September) the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) welcomed Indian entrepreneur Ashok Soota from SKAN Research Trust (SKAN) to Cambridge to mark an upcoming partnership between the two organisations that will bring cutting edge expertise in stem cell research to India. SKAN (an acronym for Scientific...

CSCI PI Maria Alcolea named one of three Cambridge researchers shortlisted for $25m Cancer Grand Challenges funding

5 September 2023

In March, Cancer Grand Challenges announced nine new challenges, with 178 interdisciplinary, world-class global teams submitting bold ideas to take them on. Today (5 September 2023), 12 teams have been shortlisted to further their research and compete for up to $25m in funding. CSCI PI Maria Alcolea has been announced as...

Cambridge and ISPA scientists create a tool to identify individuals at risk of developing different myeloid leukaemias

24 August 2023

Scientists have created a new test for identifying people at risk of developing acute myeloid leukaemia and related cancers, years before they do. The new platform, ‘MN-predict’, will allow doctors and scientists to identify those at risk and to design new treatments to prevent them from developing these potentially lethal...

Figure 7 from Nature Genetics Paper 2023

CSCI scientists complete a comprehensive study investigating chromatin factors in haematopoiesis

23 August 2023

Cambridge scientists, in collaboration with colleagues across Europe, have completed the most comprehensive study yet attempted to assess the role of chromatin factors in normal and malignant haematopoiesis, the process of blood formation, in a study published this month in Nature Genetics . The study provides an important...

Yolk sac image. Credit Megumi Inoue Institut de la Vision

Multiple organ functions of the yolk sac revealed by early human development map

18 August 2023

A study describes organ function crossover in the human yolk sac and presents a new rapid pathway for immune cell differentiation. The role of the human yolk sac in supporting early embryonic development and the first wave of the prenatal immune system has been mapped in a study published yesterday (17 August) in Science...

Celebrating the Institute's work and industry connections at the Annual Retreat

13 June 2023

Last week, the Institute held the CSCI Annual Retreat on 5 and 6 June in Cambridge. This event brings together CSCI researchers and Affiliate Group Leaders to share emerging findings, forge collaborations and socialise outside of the office and labs. This year also featured, in addition to the scientific sessions, a...

Three people stood in front of hospital building, from left to right: Matthias Zilbauer, Claire Glemas, Robert Heuschkel.

Zilbauer Group recognised for outstanding paediatric involvement and engagement efforts

31 May 2023

The Royal College of Paediatrics and Child Health (RCPCH) and National Institute of Health Research (NIHR) have awarded their 2023 Paediatric Involvement and Engagement in Research Prize to the research group led by Dr Matthias Zilbauer.

Wellcome announce funding for Cambridge Stem Cell Institute as new Discovery Research Platform for Tissue Scale Biology

4 May 2023

Discovery Research Platforms will bring together researchers, teams and networks of collaborators to develop new tools, knowledge and capabilities, with the hope of accelerating progress for the benefit of the wider global research community. Wellcome selected eight platforms to fund a total of £73 million, two of which will be hosted at the University of Cambridge.

New SCI-TIF members gather for inaugural networking dinner

25 April 2023

Last night, 24 April 2023, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF ) gather with their new members for an inaugural networking dinner to mark the start of the forum. Initiated with a launch event last November, this forum aims to unite scientists in industry and academia based on a...